canakinumab plus darbepoetin in patients with lr-mds following esa failure
Published 8 months ago • 69 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
4:48
canakinumab with darbepoetin in patients with lr-mds who are esa-refractory
-
1:04
mp0533, a cd3-engaging darpin, in r/r aml or mds/aml: preliminary results of a phase i/iia trial
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:54
a novel clinical trial endpoint for acute gvhd
-
2:41
an overview of the latest advances in hematology
-
1:45
integrating genomics into clinical hematology
-
1:17
the use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing allosct
-
0:36
versiti diagnostic labs | hematology
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
1:14
highlights in quality management from ebmt
-
1:07
key advancements in the treatment of bpdcn from ebmt 2024
-
2:26
an insight into the aims of the eurasian hematology-oncology group